While in non-small cell lung cancer, they found that TFAP2C blocked AKAP12-mediated cyclin D1 inhibition by inducing the overexpression of miR-183, which shows that TFAP2C is one of the upstream regulators of miR-183 9. The gene discussed is TFAP2C; the disease is non-small cell lung carcinoma.